| SC 13G/A | 2022-02-14 | FEDERATED HERMES, INC. | Merus N.V. | 3,679,300 | 8.5% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | Merus N.V. | 3,154,551 | 7.4% | EDGAR |
| SC 13G | 2021-08-10 | WELLINGTON MANAGEMENT GROUP LLP | Merus N.V. | 4,600,358 | 12.0% | EDGAR |
| SC 13G/A | 2021-07-07 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 2,696,674 | 7.0% | EDGAR |
| SC 13G/A | 2021-02-12 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 3,055,521 | 10.5% | EDGAR |
| SC 13G/A | 2021-02-12 | EcoR1 Capital, LLC | Merus N.V. | - | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | FEDERATED HERMES, INC. | Merus N.V. | 2,936,798 | 10.1% | EDGAR |
| SC 13G/A | 2021-02-11 | Medicxi Growth I LP | Merus N.V. | 1,562,872 | 4.2% | EDGAR |
| SC 13D/A | 2021-01-25 | INCYTE CORP | Merus N.V. | 3,550,000 | 9.4% | EDGAR |
| SC 13G | 2021-01-20 | Boxer Capital, LLC | Merus N.V. | 1,600,000 | 5.5% | EDGAR |
| SC 13D | 2020-12-28 | INCYTE CORP | Merus N.V. | 3,200,000 | 11.0% | EDGAR |
| SC 13G | 2020-11-10 | FEDERATED HERMES, INC. | Merus N.V. | 2,936,798 | 10.1% | EDGAR |
| SC 13G/A | 2020-06-03 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 2,610,548 | 9.0% | EDGAR |
| SC 13D/A | 2020-04-27 | Sofinnova Venture Partners IX, L.P. | Merus N.V. | 1,311,039 | 4.5% | EDGAR |
| SC 13G/A | 2020-04-24 | EcoR1 Capital, LLC | Merus N.V. | 1,906,861 | 6.6% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 1,604,215 | 5.6% | EDGAR |
| SC 13G/A | 2020-02-14 | BAKER BROS. ADVISORS LP | Merus N.V. | 2,037,469 | 7.1% | EDGAR |
| SC 13G/A | 2020-02-14 | Aquilo Capital Management, LLC | Merus N.V. | 814,505 | 2.8% | EDGAR |
| SC 13G | 2020-02-14 | EcoR1 Capital, LLC | Merus N.V. | 1,718,200 | 6.0% | EDGAR |
| SC 13G | 2019-11-14 | Medicxi Growth I LP | Merus N.V. | 1,562,872 | 5.4% | EDGAR |